Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells

摘要

Introduction The aim of this study is to investigate potential adverse effects of fixed combination glaucoma medications preserved with either benzalkonium chloride (BAK) or Polyquad® (PQ; Alcon Research Ltd., Fort Worth, TX, USA) on cultured ocular epithelial cells.